Successful use of albendazole and fenbendazole therapy in a cat with persistent diarrhea due Enterocytozoon bieneusi

J Vet Med Sci. 2022 Jun 18;84(6):869-871. doi: 10.1292/jvms.22-0045. Epub 2022 Apr 28.

Abstract

Enterocytozoon bieneusi, also known as microsporidia, is an obligate, opportunistic, and neglected intracellular pathogen that causes diarrhea in humans. Although identified in the cat feces by epidemiological studies, no association with diarrhea has been demonstrated. We demonstrated a case of chronic enteritis by E. bieneusi in a 1-year-old male Maine Coon cat, neutered with diarrhea for nine months, by histopathological analysis of gastrointestinal biopsies and PCR of feces. The treatment with albendazole (10 days) followed by fenbendazole (5 days) proved to be effective and safe after diagnosis. This description highlights the need to investigate these pathogens in cases of diarrhea due to their importance in public health since they are zoonotic agents.

Keywords: albendazole; enteritis; lymphoplasmacytic enteritis; microsporidiosis.

Publication types

  • Case Reports

MeSH terms

  • Albendazole / therapeutic use
  • Animals
  • Cat Diseases* / drug therapy
  • Cats
  • Diarrhea / drug therapy
  • Diarrhea / veterinary
  • Enterocytozoon*
  • Feces
  • Fenbendazole / therapeutic use
  • Genotype
  • Male
  • Microsporidiosis* / diagnosis
  • Microsporidiosis* / drug therapy
  • Microsporidiosis* / veterinary
  • Prevalence

Substances

  • Fenbendazole
  • Albendazole